K. Ogata et al. / Inorganica Chimica Acta 359 (2006) 1549–1558
1551
2.2.2. Preparation of [Cp*Rh(PPh3){C(C6H4-p-Me)@
CHC(O)CH2(C6H4-p-Me)}](PF6) (2b)
NMR(CDCl3): d 17.9 (d, JRhP = 148 Hz), ꢀ143.6 (sep.
JRhP = 713 Hz, PF6). Anal. Calc. for C39H41OF6P2Rh: C,
58.22; H, 5.14. Found: C, 58.47; H, 5.44%.
Reddish brown crystals of 2b (41.4 mg, 42.9%) obtained
from 1 (70.9 mg, 0.124 mmol), H2O (1.0 mL, 55 mmol), p-
tolylacetylene (0.1 mL, 0.8 mmol) and KPF6 (46.7 mg,
0.254 mmol) according to a procedure similar to that of
2a. FAB mass: m/z: 749 [M ꢀ 1+]. IR(nujol): 1599, 1537
2.2.6. Preparation of [Cp*RhCl(PPh3){CNC6H4-
C„CH}](PF6) (3)
A mixture of 1 (82.7 mg, 0.145 mmol), KPF6 (88.9 mg,
0.483 mmol), H2O (1.0 mL, 55 mmol) and HC„CC6H4-4-
(NC) (52.4 mg, 0.412 mmol) in CH2Cl2 (10 mL) and acetone
(15 mL) was stirred at room temperature. The reddish brown
solution changed to yellow. After 24 h, the solvent was
removed and the residue was extracted with CH2Cl2. The
solution was concentrated to 2 mL and diethyl ether was
added, affording yellow complex of 3 (96.4 mg, 82.4%).
1
(C@O and C@C), 835 cmꢀ1 (PF6). H NMR (CDCl3): d
1.20 (d, JPH = 2.6 Hz, Cp*, 15H), 1.57 (s, p-Me, 3H),
2.34 (s, p-Me, 3H), 3.11, 3.29 (AB system, JHH = 16.0 Hz,
CH2, 2H), 6.67 (s, CH, 1H), ca. 6.9–7.8 (c, ArH). 31P{1H}
NMR(CDCl3): d 38.0 (d, JRhP = 151 Hz),ꢀ143.7 (sep.
JRhP = 712 Hz, PF6). Anal. Calc. for C46H47OF6P2Rh: C,
61.75; H, 5.29. Found: C, 61.73; H, 5.22%.
IR(nujol): 3279 (C„CH), 2174 (N„C), 843 (PF6) cmꢀ1
.
2.2.3. Preparation of [Cp*Rh(PPh3){C(C6H4-p-COOMe)@
CHC(O)CH2(C6H4-p-COOMe)}](PF6) (2c)
1H NMR (CDCl3): d 1.62 (d, JPH = 3.5 Hz, Cp*), 3.20 (s,
CH, 1H), 6.8-8.0 (c, ArH, 19H). 31P{1H} NMR(CD2Cl2): d
32.3 (d, JRhP = 122 Hz), ꢀ143.7 (sep. JRhP = 713 Hz, PF6).
Anal. Calc. for C37H35NClF6P2Rh: C, 55.00; H, 4.37; N,
1.73. Found: C, 55.19; H, 4.12; N, 1.95%.
Yellow crystals of 2c (61.4 mg, 50.7%) were obtained
from 1 (70.4 mg, 0.123 mmol), H2O (1.0 mL, 55 mmol),
HC„CC6H4-p-COOMe (49.7 mg, 0.310 mmol) and KPF6
(57.8 mg, 0.314 mmol) according to a procedure similar
to that of 2a. IR(nujol): 1717 (C@O), 1543 (C@O and
C@C), 833 cmꢀ1 (PF6). 1H NMR (CD2Cl2): d 1.21 (d,
JPH = 2.6 Hz, Cp*), 3.25, 3.58 (AB system, JHH = 16.5 Hz,
CH2, 2H),, 3.91 (s, Me, 3H), 3.93 (s, Me, 3H), 6.80 (s, CH,
1H), ca. 7.0–8.4 (c, ArH, 23H). 31P{1H} NMR(CD2Cl2): d
37.2 (d, JRhP = 148 Hz), ꢀ144.7 (sep. JRhP = 712 Hz, PF6).
Anal. Calc. for C48H47O5F6P2Rh: C, 58.66; H, 4.82.
Found: C, 58.94; H, 4.80%.
2.2.7. Preparation of [Cp*Rh(PPh3){CPh@CHC(O)-
CHDPh}](PF6)
To a solution of 1 (88.7 mg, 0.155 mmol), D2O (1.0 mL,
56 mmol) and KPF6 (71.6 mg, 0.389 mmol) in CH2Cl2
(10 mL) and acetone (10 mL), phenylacetylene (0.1 mL,
1.8 mmol) was added at room temperature. After stirring
for 6 h, the solvent was removed to dryness. The residue
was washed with diethyl ether and was extracted with
CH2Cl2. Removal of the solvent and the residue was recrys-
tallized from CH2Cl2 and diethyl ether, giving reddish
brown complex (69.7 mg, 51.7%). IR(nujol): 1543 (C@C,
2.2.4. Preparation of [Cp*Rh(PPh3){CC6H4-p-NO2@
CHC(O)CH2(C6H4-p-NO2)}](PF6) (2d)
Dark-brown crystals of 2d (33.2 mg, 24.2%) were
obtained from 1 (81.9 mg, 0.143 mmol), H2O (1.0 mL,
55 mmol), HC„CC6H4-p-NO2 (62.5 mg, 0.425 mmol)
and KPF6 (71.0 mg, 0.386 mmol) according to a procedure
similar to that of 2a. IR(nujol): 1510 (C@O and C@C),
843 cmꢀ1 (PF6). FAB mass: m/z 811 ([M ꢀ 1]+). 1H
NMR (CD2Cl2): d 1.23 (d, JPH = 2.6 Hz, Cp*), 3.28, 3.82
(AB system, JHH = 16.5 Hz, CH2, 2H), 6.90 (d,
JRhH = 2.0 Hz, CH, 1H), ca. 7.0–8.4 (c, ArH, 23H).
C@O), 839 (PF6) cmꢀ1 1H NMR (CDCl3): d 1.22 (d,
.
JHP = 2.5 Hz, Cp*, 15H), 3.16 (br-s, CHD, 1H), 6.78 (s,
H, 1H), 6.9–7.8 (m, Ph, 20H). 31P{1H} NMR(CDCl3): d
38.0 (d, JRhP = 153 Hz), ꢀ143.7 (sep. JPF = 713 Hz, PF6).
2.2.8. Preparation of [{Cp*Rh(l-Cl)}2 (dppm)](PF6)2
(5)
Orange crystals of 5 (20.8 mg. 44.8%) were obtained
from [(Cp*RhCl2)2(l-dppm)] (4) (38.1 mg, 0.038 mmol),
KPF6 (32.0 mg, 0.174 mmol), phenylacetylene (0.1 mL,
0.913 mol) and H2O (0.1 mL, 5.6 mmol) according to a
procedure similar to that of 2a. FAB mass: m/z 1074
31P{1H} NMR(CD2Cl2):
d 37.1 (d, JRhP = 148 Hz),
ꢀ144.6 (sep. JRhP = 712 Hz, PF6). Anal. Calc. for
C44H41N2O5F6P2Rh: C, 55.24; H, 4.32; N, 2.93. Found:
C, 55.02; H, 4.33; N, 3.12%.
1
([M + PF6]+), 931 ([M]+). IR (nujol): 835 (PF6) cmꢀ1. H
NMR (CD3COCD3): d 1.49 (d, JHP = 3.5 Hz, Cp*, 30H),
4.30 (t, JHP = 12.0 Hz, CH2, 2H), 7.4–7.7 (m, Ph, 15H).
31P{1H} NMR(CD3COCD3): d 25.4 (d, JPRh = 147.0 Hz),
ꢀ143.3 (sep. JPF = 712 Hz, PF6). Anal. Calc. for
C45H52P4Cl2F12Rh2: C, 44.25; H, 4.29. Found: C, 44.53;
H, 4.22%.
2.2.5. Preparation of [Cp*Rh(PMePh2)-
{CPh@CHC(O)CH2 Ph}](PF6) (2e)
Yellow crystals of 2e (54.1 mg, 61.5%) were obtained
from Cp*RhCl2(PMePh2) (1e) (55.7 mg, 0.11 mmol), phe-
nylacetylene (0.1 mL, 0.9 mmol), H2O (1.0 mL, 55 mmol)
and KPF6 (43.6 mg, 0.237 mmol) according to a procedure
similar to that of 2a. IR(nujol): 1545 (C@O or C@C), 839
2.3. Preparation of iridium and ruthenium complexes
1
(PF6) cmꢀ1. H NMR (CDCl3): d 1.25 (d, JPH = 2.5 Hz,
Cp*, 15H), 2.07 (d, JPH = 9.0 Hz, Me, 3H), 3.61, 3.72
(AB system, JHH = 15.5 Hz, CH2, 2H), 6.65 (d,
JRhH = 2.0 Hz, CH, 1H), 6.8–8.0 (c, ArH, 19H). 31P{1H}
2.3.1. Preparation of [Cp*IrCl(PPh3)(CO)](PF6) (8)
To a solution of 6 (101 mg, 0.152 mmol) and NaPF6
(96.5 mg, 0.575 mmol) in CH2Cl2 (15 mL) and acetone